JACE CLINICAL SOLUTIONS

Serial Number 88380051
602

Registration Progress

Application Filed
Apr 10, 2019
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

JACE CLINICAL SOLUTIONS

Basic Information

Serial Number
88380051
Filing Date
April 10, 2019
Abandonment Date
May 11, 2021
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Jul 22, 2021
Classes
005

Rights Holder

Fitzer, Brian D

01
Address
3119 W Barcelona Street B
Tampa, FL 33629

Ownership History

Fitzer, Brian D

Original Applicant
01
Tampa, FL

Legal Representation

Attorney
Patricia A. Hughel

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

18 events
Date Code Type Description Documents
Jul 22, 2021 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Jul 22, 2021 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Jul 21, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
May 24, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 10, 2020 GNFR O FINAL REFUSAL E-MAILED Loading...
Nov 10, 2020 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Nov 10, 2020 CNFR R FINAL REFUSAL WRITTEN Loading...
Oct 8, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 8, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 8, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 9, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 9, 2020 GNRT F NON-FINAL ACTION E-MAILED Loading...
Apr 9, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 25, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 21, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 20, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 27, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 13, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Nutritional supplements; any CBD in the goods being solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"CLINICAL SOLUTIONS"